On August 5, 2021 Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)- based DNA manufacturing and nucleic acid-based technologies, reported that it will report fiscal 2021 third quarter financial results after market close on Thursday, August 12, 2021 (Press release, Applied DNA Sciences, AUG 5, 2021, View Source [SID1234585846]). The Company’s management will discuss the results during a conference call and simultaneous webcast at 4:30 p.m. EDT that same day. Presentation slides will also be posted to the ‘IR Calendar and Corporate Presentations’ sub-page of the Company’s corporate website and embedded into the live webcast.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call and Webcast Information – Live
Date: Thursday, August 12, 2021, at 4:30 p.m. Eastern Daylight Time
Dial in: 844-887-9402, 412-317-6798 (international)
Hosts: Dr. James A. Hayward, chairman, president, and CEO, Beth Jantzen, chief financial officer
Webcast: View Source

Conference Call and Webcast Information – Replay
A telephonic replay of the conference call will be available for one week beginning one hour after the end of the live conference call.

Dial in: 877-344-7529, 412-317-0088 (international), Access Code: 10158254
Webcast: View Source
Availability: Telephonic replay: until Thursday, August 19, 2021; webcast replay: 1 year

The webcast and accompanying PowerPoint presentation will also be archived on the ‘IR Calendar and Corporate Presentations’ page listed under the Investor Relations drop-down menu on the Company’s website.